Cargando…
The Emerging Role of c-Met in Carcinogenesis and Clinical Implications as a Possible Therapeutic Target
BACKGROUND: c-MET is a receptor tyrosine kinase receptor (RTK) for the hepatocyte growth factor (HGF). The binding of HGF to c-MET regulates several cellular functions: differentiation, proliferation, epithelial cell motility, angiogenesis, and epithelial-mesenchymal transition (EMT). Moreover, it i...
Autores principales: | Faiella, Antonio, Riccardi, Ferdinando, Cartenì, Giacomo, Chiurazzi, Martina, Onofrio, Livia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776431/ https://www.ncbi.nlm.nih.gov/pubmed/35069735 http://dx.doi.org/10.1155/2022/5179182 |
Ejemplares similares
-
Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities
por: Zhang, Yazhuo, et al.
Publicado: (2018) -
Incidental finding of non-Hodgkin's lymphoma in a patient affected by castration-sensitive prostate cancer: A case report
por: Pirozzi, Angelo, et al.
Publicado: (2019) -
c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase
por: Szabo, Roman, et al.
Publicado: (2011) -
Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract: A case report
por: Pirozzi, Angelo, et al.
Publicado: (2019) -
c-Met: A Promising Therapeutic Target in Bladder Cancer
por: Feng, Yanfei, et al.
Publicado: (2022)